Latest news
AIM ImmunoTech Reports Completion of Phase 2 Ampligen Dosing in Metastatic Pancreatic Cancer Trial, Advances Phase 3 Planning - Quiver QuantitativeQuiver Quantitative · Mon, 10 Aug 2026 12:47:00 GMTCAMP4 advances rare disease treatment for SYNGAP1 into human trials - CNBCCNBC · Thu, 06 Aug 2026 18:52:12 GMTS.D.-born biotech advances potential Type 1 diabetes therapy through global trial - SiouxFalls.BusinessSiouxFalls.Business · Thu, 06 Aug 2026 14:35:40 GMTPact trial advances soft plastics recycling in NZ - PKN Packaging NewsPKN Packaging News · Thu, 06 Aug 2026 05:48:10 GMTEntropy Neurodynamics (ASX:ENP): TRP-8803 Clinical Trial Advances - KalkineKalkine · Tue, 04 Aug 2026 00:44:00 GMTDefense attorney reacts to Lindsay Clancy's trial developments - Fox NewsFox News · Sat, 01 Aug 2026 07:00:00 GMTNeurotech Secures FDA IND Clearance for NTI164 as Phase 3 Autism Trial Advances - KalkineKalkine · Fri, 31 Jul 2026 07:00:00 GMTAtavistik Bio Partners with Cure HHT Clinical Trial Network - GlobeNewswireGlobeNewswire · Thu, 30 Jul 2026 11:00:00 GMT